Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

GSK Revenue 2010-2025 | GSK

GSK annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • GSK revenue for the quarter ending March 31, 2025 was $9.466B, a 1.39% increase year-over-year.
  • GSK revenue for the twelve months ending March 31, 2025 was $40.225B, a 4.16% increase year-over-year.
  • GSK annual revenue for 2024 was $40.095B, a 6.28% increase from 2023.
  • GSK annual revenue for 2023 was $37.725B, a 4.01% increase from 2022.
  • GSK annual revenue for 2022 was $36.271B, a 22.68% decline from 2021.
  
GSK Annual Revenue
(Millions of US $)
2024 $40,095
2023 $37,725
2022 $36,271
2021 $46,910
2020 $43,783
2019 $43,100
2018 $41,140
2017 $38,904
2016 $37,798
2015 $36,578
2014 $37,916
2013 $41,475
2012 $41,896
2011 $43,940
2010 $43,903
2009 $44,421
GSK Quarterly Revenue
(Millions of US $)
2025-03-31 $9,466
2024-12-31 $10,388
2024-09-30 $10,420
2024-06-30 $9,950
2024-03-31 $9,337
2023-12-31 $9,980
2023-09-30 $10,313
2023-06-30 $8,988
2023-03-31 $8,444
2022-12-31 $5,228
2022-09-30 $9,221
2022-06-30 $8,699
2022-03-31 $13,123
2021-12-31 $12,853
2021-09-30 $12,516
2021-06-30 $11,311
2021-03-31 $10,229
2020-12-31 $11,509
2020-09-30 $11,169
2020-06-30 $9,461
2020-03-31 $11,644
2019-12-31 $11,509
2019-09-30 $11,573
2019-06-30 $10,040
2019-03-31 $9,978
2018-12-31 $6,661
2018-09-30 $10,544
2018-06-30 $9,949
2018-03-31 $13,986
2017-12-31 $10,128
2017-09-30 $10,268
2017-06-30 $9,361
2017-03-31 $9,147
2016-12-31 $9,429
2016-09-30 $9,905
2016-06-30 $9,373
2016-03-31 $8,925
2015-12-31 $9,617
2015-09-30 $9,498
2015-06-30 $9,020
2015-03-31 $8,512
2014-12-31 $9,319
2014-09-30 $9,120
2014-06-30 $9,472
2014-03-31 $9,440
2013-12-31 $11,235
2013-09-30 $10,518
2013-06-30 $10,166
2013-03-31 $9,875
2012-12-31 $10,782
2012-09-30 $10,512
2012-06-30 $10,210
2012-03-31 $10,717
2011-12-31 $10,990
2011-09-30 $11,304
2011-06-30 $10,950
2011-03-31 $10,544
2010-12-31 $11,636
2010-09-30 $10,560
2010-06-30 $9,196
2010-03-31 $11,286
2009-12-31 $13,218
2009-09-30 $11,097
2009-06-30 $10,527
2009-03-31 $9,734
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $79.928B $40.096B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $219.635B 16.39
Amgen (AMGN) United States $159.441B 14.28
Gilead Sciences (GILD) United States $140.863B 14.63
Vertex Pharmaceuticals (VRTX) United States $122.997B 0.00
Bristol Myers Squibb (BMY) United States $96.992B 6.49
CSL (CSLLY) Australia $77.619B 0.00
Regeneron Pharmaceuticals (REGN) United States $59.660B 14.48
Alnylam Pharmaceuticals (ALNY) United States $41.838B 0.00
Argenex SE (ARGX) Netherlands $33.900B 92.53
BioNTech SE (BNTX) Germany $26.871B 0.00
Royalty Pharma (RPRX) United States $20.168B 8.52
Biogen (BIIB) United States $19.491B 8.41
Insmed (INSM) United States $18.302B 0.00
Illumina (ILMN) United States $15.425B 29.26
Genmab (GNMSF) Denmark $14.206B 14.53
Genmab (GMAB) Denmark $13.844B 15.52
Incyte (INCY) United States $13.302B 101.06
Moderna (MRNA) United States $12.681B 0.00
Exelixis (EXEL) United States $12.018B 20.40
BioMarin Pharmaceutical (BMRN) United States $11.443B 18.59
Ascendis Pharma (ASND) Denmark $10.742B 0.00
QIAGEN (QGEN) Netherlands $10.661B 20.74
Exact Sciences (EXAS) United States $10.434B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.919B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $8.604B 0.00
Blueprint Medicines (BPMC) United States $8.302B 0.00
Bio-Techne Corp (TECH) United States $8.244B 30.75
Roivant Sciences (ROIV) United Kingdom $7.627B 0.00
Anbio Biotechnology (NNNN) Germany $7.455B 0.00
Repligen (RGEN) United States $7.294B 81.65
Legend Biotech (LEGN) United States $7.250B 0.00
Revolution Medicines (RVMD) United States $7.175B 0.00
Halozyme Therapeutics (HALO) United States $6.972B 13.34
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Jazz Pharmaceuticals (JAZZ) Ireland $6.753B 6.63
Guardant Health (GH) United States $6.323B 0.00
TG Therapeutics (TGTX) United States $6.020B 158.00
Nuvalent (NUVL) United States $5.852B 0.00
Telix Pharmaceuticals (TLX) Australia $5.725B 0.00
Rhythm Pharmaceuticals (RYTM) United States $5.662B 0.00
Axsome Therapeutics (AXSM) United States $5.532B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.189B 0.00
Alkermes (ALKS) Ireland $4.944B 13.27
Vaxcyte (PCVX) United States $4.616B 0.00
ADMA Biologics Inc (ADMA) United States $4.378B 32.75
Cytokinetics (CYTK) United States $4.374B 0.00
Krystal Biotech (KRYS) United States $4.303B 33.16
Zealand Pharma (ZLDPF) Denmark $4.230B 0.00
Akero Therapeutics (AKRO) United States $4.076B 0.00
Zai Lab (ZLAB) China $3.961B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.918B 0.00
PTC Therapeutics (PTCT) United States $3.863B 6.72
Arcellx (ACLX) United States $3.802B 0.00
Merus (MRUS) Netherlands $3.773B 0.00
Avidity Biosciences (RNA) United States $3.769B 0.00
Metsera (MTSR) United States $3.711B 0.00
Scholar Rock Holding (SRRK) United States $3.512B 0.00
Viking Therapeutics (VKTX) United States $3.414B 0.00
Protagonist Therapeutics (PTGX) United States $3.241B 69.72
MoonLake Immunotherapeutics (MLTX) Switzerland $3.091B 0.00
Immunovant (IMVT) United States $2.955B 0.00
Kymera Therapeutics (KYMR) United States $2.942B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.841B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.648B 0.00
Alvotech (ALVO) Luxembourg $2.635B 15.07
Arrowhead Pharmaceuticals (ARWR) United States $2.607B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.508B 0.00
ImmunityBio (IBRX) United States $2.463B 0.00
Apellis Pharmaceuticals (APLS) United States $2.414B 0.00
Ligand Pharmaceuticals (LGND) United States $2.362B 0.00
Twist Bioscience (TWST) United States $2.344B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.272B 0.00
Agios Pharmaceuticals (AGIO) United States $2.263B 0.00
Denali Therapeutics (DNLI) United States $2.179B 0.00
Beam Therapeutics (BEAM) United States $2.158B 0.00
Bavarian Nordic (BVNRY) Denmark $2.157B 11.40
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.102B 0.00
Vericel (VCEL) United States $2.089B 1383.33
CG Oncology (CGON) United States $2.061B 0.00
Belite Bio (BLTE) United States $2.043B 0.00
NovoCure (NVCR) Jersey $2.028B 0.00
IDEAYA Biosciences (IDYA) United States $2.012B 0.00
Amicus Therapeutics (FOLD) United States $1.977B 214.00
Harmony Biosciences Holdings (HRMY) United States $1.969B 13.09
Disc Medicine (IRON) United States $1.935B 0.00
Sarepta Therapeutics (SRPT) United States $1.904B 0.00
Certara (CERT) United States $1.861B 34.76
Adaptive Biotechnologies (ADPT) United States $1.812B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.737B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.735B 0.00
Apogee Therapeutics (APGE) United States $1.705B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.695B 0.00
Vera Therapeutics (VERA) United States $1.544B 0.00
89BIO (ETNB) United States $1.542B 0.00
GRAIL (GRAL) United States $1.516B 0.00
Janux Therapeutics (JANX) United States $1.508B 0.00
Celldex Therapeutics (CLDX) United States $1.491B 0.00
Edgewise Therapeutics (EWTX) United States $1.482B 0.00
Biohaven (BHVN) United States $1.479B 0.00
Travere Therapeutics (TVTX) United States $1.450B 0.00
ANI Pharmaceuticals (ANIP) United States $1.415B 14.58
Viridian Therapeutics (VRDN) United States $1.390B 0.00
Mesoblast (MESO) Australia $1.343B 0.00
Dynavax Technologies (DVAX) United States $1.298B 77.21
Intellia Therapeutics (NTLA) United States $1.256B 0.00
CureVac (CVAC) Germany $1.234B 5.98
WAVE Life Sciences (WVE) Singapore $1.198B 0.00
Cogent Biosciences (COGT) United States $1.184B 0.00
MannKind (MNKD) United States $1.161B 23.88
Liquidia Technologies (LQDA) United States $1.152B 0.00
Novavax (NVAX) United States $1.140B 2.66
Structure Therapeutics (GPCR) United States $1.095B 0.00
Pacira BioSciences (PCRX) United States $1.073B 10.21
MiMedx (MDXG) United States $1.028B 24.86
Cidara Therapeutics (CDTX) United States $1.028B 0.00
Praxis Precision Medicines (PRAX) United States $1.023B 0.00
Nurix Therapeutics (NRIX) United States $1.005B 0.00
Spyre Therapeutics (SYRE) United States $0.998B 0.00
Arcus Biosciences (RCUS) United States $0.988B 0.00
LENZ Therapeutics (LENZ) United States $0.980B 0.00
NeoGenomics (NEO) United States $0.969B 0.00
Pharvaris (PHVS) Netherlands $0.967B 0.00
BGM Group (BGM) China $0.958B 0.00
Niagen Bioscience (NAGE) United States $0.955B 134.67
Zymeworks (ZYME) United States $0.946B 0.00
Mineralys Therapeutics (MLYS) United States $0.937B 0.00
Oric Pharmaceuticals (ORIC) United States $0.929B 0.00
Sionna Therapeutics (SION) United States $0.924B 0.00
Anavex Life Sciences (AVXL) United States $0.919B 0.00
Geron (GERN) United States $0.917B 0.00
Sana Biotechnology (SANA) United States $0.913B 0.00
Vir Biotechnology (VIR) United States $0.820B 0.00
UniQure (QURE) Netherlands $0.815B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
Nuvation Bio (NUVB) United States $0.806B 0.00
GH Research (GHRS) Ireland $0.805B 0.00
Oculis Holding AG (OCS) Switzerland $0.805B 0.00
Replimune (REPL) United States $0.801B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.795B 0.00
Immunome (IMNM) United States $0.774B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
CorMedix Inc (CRMD) United States $0.770B 51.59
AnaptysBio (ANAB) United States $0.756B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.754B 0.00
Gyre Therapeutics (GYRE) United States $0.750B 200.00
ArriVent BioPharma (AVBP) United States $0.730B 0.00
Trevi Therapeutics (TRVI) United States $0.724B 0.00
Immatics (IMTX) Germany $0.717B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.710B 0.00
Jyong Biotech (MENS) Taiwan $0.703B 0.00
Pharming Group (PHAR) Netherlands $0.681B 0.00
Dianthus Therapeutics (DNTH) United States $0.678B 0.00
MeiraGTx Holdings (MGTX) United States $0.673B 0.00
Iovance Biotherapeutics (IOVA) United States $0.665B 0.00
Maze Therapeutics (MAZE) United States $0.660B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.657B 0.00
Stoke Therapeutics (STOK) United States $0.656B 15.22
Tango Therapeutics (TNGX) United States $0.655B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.654B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.648B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Urogen Pharma (URGN) United States $0.637B 0.00
Upstream Bio (UPB) United States $0.629B 0.00
Prime Medicine (PRME) United States $0.611B 0.00
Arvinas (ARVN) United States $0.601B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.583B 0.00
Keros Therapeutics (KROS) United States $0.582B 0.00
Castle Biosciences (CSTL) United States $0.581B 39.45
Sage Therapeutics (SAGE) United States $0.576B 0.00
Precigen (PGEN) United States $0.561B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.554B 0.00
Tyra Biosciences (TYRA) United States $0.542B 0.00
Kura Oncology (KURA) United States $0.533B 0.00
Bicara Therapeutics (BCAX) United States $0.527B 0.00
Myriad Genetics (MYGN) United States $0.527B 0.00
Opthea (OPT) Australia $0.525B 0.00
Septerna (SEPN) United States $0.522B 0.00
Celcuity (CELC) United States $0.512B 0.00
Rapport Therapeutics (RAPP) United States $0.511B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.505B 0.00
ATyr Pharma (ATYR) United States $0.492B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.467B 0.00
Cullinan Therapeutics (CGEM) United States $0.460B 0.00
REGENXBIO (RGNX) United States $0.460B 0.00
Fortrea Holdings (FTRE) United States $0.456B 12.60
Cytek Biosciences (CTKB) United States $0.453B 0.00
Rezolute (RZLT) United States $0.452B 0.00
Kamada (KMDA) Israel $0.451B 27.07
MBX Biosciences (MBX) United States $0.444B 0.00
PureTech Health (PRTC) United States $0.440B 0.00
Zenas BioPharma (ZBIO) United States $0.439B 0.00
Erasca (ERAS) United States $0.436B 0.00
Solid Biosciences (SLDB) United States $0.428B 0.00
Terns Pharmaceuticals (TERN) United States $0.427B 0.00
Fulcrum Therapeutics (FULC) United States $0.427B 0.00
Eton Pharmaceuticals (ETON) United States $0.423B 0.00
Tectonic Therapeutic (TECX) United States $0.402B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.401B 0.00
Emergent Biosolutions (EBS) United States $0.398B 0.00
Humacyte (HUMA) United States $0.394B 0.00
ITeos Therapeutics (ITOS) United States $0.392B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.387B 0.00
Astria Therapeutics (ATXS) United States $0.382B 0.00
Vigil Neuroscience (VIGL) United States $0.382B 0.00
Compass Therapeutics (CMPX) United States $0.379B 0.00
Benitec Biopharma (BNTC) United States $0.363B 0.00
Amarin (AMRN) Ireland $0.359B 0.00
Cartesian Therapeutics (RNAC) United States $0.357B 0.00
Prothena (PRTA) Ireland $0.354B 0.00
Northwest Biotherapeutics (NWBO) United States $0.344B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.342B 0.00
Olema Pharmaceuticals (OLMA) United States $0.341B 0.00
XOMA Royalty (XOMA) United States $0.332B 0.00
Aura Biosciences (AURA) United States $0.331B 0.00
Ocugen (OCGN) United States $0.330B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.325B 66.12
Inventiva S.A (IVA) France $0.323B 0.00
Atea Pharmaceuticals (AVIR) United States $0.322B 0.00
Vor Biopharma (VOR) $0.317B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.312B 0.00
Citius Oncology (CTOR) United States $0.311B 0.00
Gossamer Bio (GOSS) United States $0.309B 0.00
Foghorn Therapeutics (FHTX) United States $0.307B 0.00
Candel Therapeutics (CADL) United States $0.305B 0.00
Annexon (ANNX) United States $0.304B 0.00
Neurogene (NGNE) United States $0.303B 0.00
Inhibrx Biosciences (INBX) United States $0.303B 0.18
Lifecore Biomedical (LFCR) United States $0.302B 0.00
DBV Technologies S.A (DBVT) France $0.301B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.296B 0.00
Sagimet Biosciences (SGMT) United States $0.291B 0.00
Crescent Biopharma (CBIO) United States $0.289B 0.00
Entrada Therapeutics (TRDA) United States $0.287B 9.35
Zhengye Biotechnology Holding (ZYBT) China $0.287B 0.00
Palvella Therapeutics (PVLA) United States $0.285B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.285B 0.00
Alpha Teknova (TKNO) United States $0.282B 0.00
Cardiff Oncology (CRDF) United States $0.271B 0.00
Allogene Therapeutics (ALLO) United States $0.265B 0.00
Verastem (VSTM) United States $0.264B 0.00
Editas Medicine (EDIT) United States $0.258B 0.00
Monopar Therapeutics (MNPR) United States $0.247B 0.00
Prima BioMed (IMMP) Australia $0.247B 0.00
Third Harmonic Bio (THRD) United States $0.246B 0.00
Adherex Technologies (FENC) United States $0.245B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.242B 0.00
Codexis (CDXS) United States $0.241B 0.00
MaxCyte (MXCT) United States $0.239B 0.00
Design Therapeutics (DSGN) United States $0.237B 0.00
Kodiak Sciences (KOD) United States $0.234B 0.00
Semper Paratus Acquisition (TVGN) United States $0.228B 0.00
Adocia (ADOCY) France $0.216B 0.00
ScPharmaceuticals (SCPH) United States $0.215B 0.00
CARGO Therapeutics (CRGX) United States $0.212B 0.00
AC Immune (ACIU) Switzerland $0.209B 0.00
Tvardi Therapeutics (TVRD) United States $0.207B 0.00
BioStem Technologies (BSEM) $0.205B 8.33
Eledon Pharmaceuticals (ELDN) United States $0.204B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.201B 0.00
CytomX Therapeutics (CTMX) United States $0.201B 5.19
Eupraxia Pharmaceuticals (EPRX) Canada $0.196B 0.00
EnGene Holdings (ENGN) Canada $0.196B 0.00
Voyager Therapeutics (VYGR) United States $0.192B 0.00
Alumis (ALMS) United States $0.190B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
SELLAS Life Sciences (SLS) United States $0.190B 0.00
I-Mab (IMAB) United States $0.189B 0.00
Bright Minds Biosciences (DRUG) United States $0.187B 0.00
Puma Biotechnology (PBYI) United States $0.179B 4.68
Tiziana Life Sciences (TLSA) United Kingdom $0.176B 0.00
Alpha Cognition (ACOG) Canada $0.173B 0.00
Ventyx Biosciences (VTYX) United States $0.171B 0.00
Spero Therapeutics (SPRO) United States $0.170B 0.00
Nuvectis Pharma (NVCT) United States $0.169B 0.00
Instil Bio (TIL) United States $0.168B 0.00
BioAge Labs (BIOA) United States $0.166B 0.00
DiaMedica Therapeutics (DMAC) United States $0.165B 0.00
Alector (ALEC) United States $0.165B 0.00
Neumora Therapeutics (NMRA) United States $0.165B 0.00
Caribou Biosciences (CRBU) United States $0.163B 0.00
Immuneering (IMRX) United States $0.160B 0.00
Anika Therapeutics (ANIK) United States $0.160B 0.00
Innate Pharma S.A (IPHA) France $0.159B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.155B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.152B 0.00
Black Diamond Therapeutics (BDTX) United States $0.150B 44.00
Compugen (CGEN) Israel $0.149B 0.00
Molecular Partners AG (MOLN) Switzerland $0.145B 0.00
Theratechnologies (THTX) Canada $0.144B 0.00
C4 Therapeutics (CCCC) United States $0.143B 0.00
Agenus (AGEN) United States $0.142B 0.00
Greenwich LifeSciences (GLSI) United States $0.141B 0.00
Rapt Therapeutics (RAPT) United States $0.140B 0.00
Kyverna Therapeutics (KYTX) United States $0.134B 0.00
Elicio Therapeutics (ELTX) United States $0.133B 0.00
Fate Therapeutics (FATE) United States $0.132B 0.00
Skye Bioscience (SKYE) United States $0.131B 0.00
Genelux (GNLX) United States $0.131B 0.00
Actuate Therapeutics (ACTU) United States $0.130B 0.00
23andMe Holding (MEHCQ) United States $0.129B 0.00
Nkarta (NKTX) United States $0.128B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.128B 0.00
Seer (SEER) United States $0.128B 0.00
Sangamo Therapeutics (SGMO) United States $0.123B 0.00
BioHarvest Sciences (BHST) Canada $0.120B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.114B 0.00
Oncolytics Biotech (ONCY) Canada $0.113B 0.00
Tenaya Therapeutics (TNYA) United States $0.109B 0.00
TuHURA Biosciences (HURA) United States $0.109B 0.00
Seres Therapeutics (MCRB) United States $0.108B 0.00
HilleVax (HLVX) United States $0.106B 0.00
TScan Therapeutics (TCRX) United States $0.104B 0.00
Coya Therapeutics (COYA) United States $0.104B 0.00
Contineum Therapeutics (CTNM) United States $0.104B 0.00
Nautilus Biotechnology (NAUT) United States $0.103B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
Elutia (ELUT) United States $0.101B 0.00
Coherus Oncology (CHRS) United States $0.101B 0.00
OKYO Pharma (OKYO) $0.099B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.099B 0.00
IO Biotech (IOBT) Denmark $0.095B 0.00
Whitehawk Therapeutics (WHWK) United States $0.095B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.094B 0.00
XBiotech (XBIT) United States $0.093B 0.00
BeyondSpring (BYSI) United States $0.093B 0.00
Zura Bio (ZURA) United States $0.092B 0.00
Climb Bio (CLYM) United States $0.091B 0.00
Cellectis S.A (CLLS) France $0.090B 0.00
Invivyd (IVVD) United States $0.090B 0.00
Adagene (ADAG) China $0.089B 0.00
Cabaletta Bio (CABA) United States $0.087B 0.00
EXoZymes (EXOZ) United States $0.085B 0.00
TELA Bio (TELA) United States $0.085B 0.00
Pliant Therapeutics (PLRX) United States $0.083B 0.00
Entera Bio (ENTX) Israel $0.083B 0.00
Forte Biosciences (FBRX) United States $0.082B 0.00
IGM Biosciences (IGMS) United States $0.081B 0.00
Quince Therapeutics (QNCX) United States $0.078B 0.00
Immunic (IMUX) United States $0.077B 0.00
Immix Biopharma (IMMX) United States $0.077B 0.00
Biomea Fusion (BMEA) United States $0.073B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.073B 0.00
VistaGen Therapeutics (VTGN) United States $0.073B 0.00
Genenta Science S.p.A (GNTA) Italy $0.072B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.071B 0.00
Alto Neuroscience (ANRO) United States $0.070B 0.00
Clearside Biomedical (CLSD) United States $0.068B 0.00
Repare Therapeutics (RPTX) Canada $0.068B 0.00
Sutro Biopharma (STRO) United States $0.066B 0.00
Opus Genetics (IRD) United States $0.066B 0.00
Oncobiologics (OTLK) United States $0.065B 0.00
Ikena Oncology (IKNA) United States $0.065B 0.00
MediciNova (MNOV) United States $0.062B 0.00
Senti Biosciences (SNTI) United States $0.061B 0.00
Connect Biopharma Holdings (CNTB) United States $0.060B 0.00
PDS Biotechnology (PDSB) United States $0.060B 0.00
InflaRx (IFRX) Germany $0.060B 0.00
Cue Biopharma (CUE) United States $0.059B 0.00
Fortress Biotech (FBIO) United States $0.059B 0.00
Adlai Nortye (ANL) Cayman Islands $0.058B 0.00
CervoMed (CRVO) United States $0.058B 0.00
Applied Therapeutics (APLT) United States $0.056B 0.00
INmune Bio (INMB) United States $0.056B 0.00
Jasper Therapeutics (JSPR) United States $0.055B 0.00
Atara Biotherapeutics (ATRA) United States $0.055B 0.00
Renovaro (RENB) United States $0.053B 0.00
ZIVO Bioscience (ZIVO) United States $0.053B 0.00
Inovio Pharmaceuticals (INO) United States $0.053B 0.00
Adverum Biotechnologies (ADVM) United States $0.053B 0.00
Annovis Bio (ANVS) United States $0.053B 0.00
Aligos Therapeutics (ALGS) United States $0.053B 0.00
VTv Therapeutics (VTVT) United States $0.053B 0.00
Precision BioSciences (DTIL) United States $0.052B 0.00
Earth Science Tech (ETST) United States $0.052B 0.00
Celularity (CELU) United States $0.051B 0.00
Quantum Biopharma (QNTM) Canada $0.049B 0.00
RenovoRx (RNXT) United States $0.048B 0.00
Werewolf Therapeutics (HOWL) United States $0.048B 0.00
Kalaris Therapeutics (KLRS) United States $0.048B 0.00
Medicus Pharma (MDCX) United States $0.045B 0.00
Exicure (XCUR) United States $0.045B 0.00
Scilex Holding (SCLX) United States $0.044B 0.00
Pluri (PLUR) Israel $0.043B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.043B 0.00
Artiva Biotherapeutics (ARTV) United States $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.042B 0.00
Mersana Therapeutics (MRSN) United States $0.042B 0.00
KALA BIO (KALA) United States $0.041B 0.00
Shattuck Labs (STTK) United States $0.039B 0.00
PepGen (PEPG) United States $0.039B 0.00
Xilio Therapeutics (XLO) United States $0.038B 0.00
Rani Therapeutics Holdings (RANI) United States $0.038B 0.00
Lantern Pharma (LTRN) United States $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.036B 0.00
Alterity Therapeutics - (ATHE) Australia $0.035B 0.00
OnKure Therapeutics (OKUR) United States $0.034B 0.00
Kezar Life Sciences (KZR) United States $0.033B 0.00
Rein Therapeutics (RNTX) United States $0.033B 0.00
Cognition Therapeutics (CGTX) United States $0.033B 0.00
Radiopharm Theranostics - (RADX) Australia $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
Clene (CLNN) United States $0.032B 0.00
Femasys (FEMY) United States $0.032B 0.00
Eyenovia (HYPD) United States $0.031B 0.00
Ovid Therapeutics (OVID) United States $0.031B 0.00
CAMP4 Therapeutics (CAMP) United States $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Dyadic (DYAI) United States $0.029B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.029B 0.00
Passage Bio (PASG) United States $0.027B 0.00
ALX Oncology Holdings (ALXO) United States $0.027B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.026B 0.00
Generation Bio (GBIO) United States $0.025B 0.00
FibroBiologics (FBLG) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
SAB Biotherapeutics (SABS) United States $0.024B 0.00
BioAtla (BCAB) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
CalciMedica (CALC) United States $0.023B 0.00
Longeveron (LGVN) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
Dare Bioscience (DARE) United States $0.022B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Cingulate (CING) United States $0.019B 0.00
Curis (CRIS) United States $0.019B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.019B 0.00
Hoth Therapeutics (HOTH) United States $0.019B 0.00
Rallybio (RLYB) United States $0.019B 0.00
Q32 Bio (QTTB) United States $0.018B 0.00
Beyond Air (XAIR) United States $0.018B 0.00
Gelteq (GELS) Australia $0.018B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.018B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.016B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.015B 0.00
Advanced Biomed (ADVB) United States $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
BRIACELL THERAP (BCTX) Canada $0.014B 0.00
Leap Therapeutics (LPTX) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
Mustang Bio (MBIO) United States $0.014B 0.00
MetaVia (MTVA) United States $0.014B 0.00
Promis Neurosciences (PMN) Canada $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Imunon (IMNN) United States $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Equillium (EQ) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
Artelo Biosciences (ARTL) United States $0.012B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.011B 0.00
LakeShore Biopharma (LSB) China $0.011B 0.00
GeoVax Labs (GOVX) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.010B 0.00
Synaptogenix (TAOX) United States $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.010B 0.00
X4 Pharmaceuticals (XFOR) United States $0.010B 0.00
Novogen (KZIA) Australia $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Jade Biosciences (JBIO) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
IN8bio (INAB) United States $0.008B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Apollomics (APLM) United States $0.006B 0.00
Mainz Biomed (MYNZ) Germany $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00